Long term rehabilitation centers, long term drug treatment facilities, alcohol treatment centers – The Fall 2010 International Treatment Center’s Cooperative Conference held in Vero Beach, Florida co-sponsored by Southworth Associates and The Gonzalez Recovery Residences was a sold out two day affair. The conference is designed to help some of the top treatment centers connect andnetwork. In attendance were the admissions, medical, treatment, discharge planning clinicians and marketing personnel of some of the leading organizations in the addiction treatment field. A variety of interventionists, detox centers, inpatient drug rehab facilities, Long term rehabilitation centers, long term drug treatment facilities, and long term alcohol treatment centers attended the two days of informal networking and formal presentation opportunities with the other attendees. During the formal presentation, the attending organizations highlighted three distinguishing features of, and recent developments to, their respective Programs. Attendees enjoyed meals and networking opportunities. ITCC Video 1 10-17-2010

 

New data for Novartis drug LucentisR confirms long–term efficacy and safety …

Filed under: long term drug treatment

Novartis International AG / New data for Novartis drug LucentisR confirms long-term efficacy and safety profile and benefits of individualized treatment . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the …
Read more on Reuters

 

No QoL Hit with Long–Term Finasteride

Filed under: long term drug treatment

Finasteride therapy for as long as 7 years had only a minor impact on physical function, accounting for less than a one-point decrement over time, beginning 3 months before initiation of therapy. Similarly, long-term treatment with the drug had no …
Read more on MedPage Today

 

Medtronic Study Confirms Long–Term Safety of Drug-Eluting Coronary Stents

Filed under: long term drug treatment

MINNEAPOLIS and MUNICH — August 27, 2012 — Results of a landmark clinical trial, PROTECT, presented for the first time today at the 2012 European Society of Cardiology (ESC) Congress, confirm the long-term safety of drug-eluting stents in the …
Read more on Reuters